Get the Stockscreener App
12.11
4.27%
-0.54
After Hours:
12.15
0.04
+0.33%
Carlsmed Inc stock is traded at $12.11, with a volume of 335.13K.
It is down -4.27% in the last 24 hours and up +14.03% over the past month.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
See More
Previous Close:
$12.65
Open:
$12.88
24h Volume:
335.13K
Relative Volume:
1.97
Market Cap:
$329.21M
Revenue:
$50.51M
Net Income/Loss:
$-29.63M
P/E Ratio:
-10.57
EPS:
-1.1459
Net Cash Flow:
-
1W Performance:
+9.99%
1M Performance:
+14.03%
6M Performance:
-3.04%
1Y Performance:
+0.00%
1-Day Range:
$12.09
$13.00
1-Week Range:
$10.29
$13.01
52-Week Range:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
858-295-9290
Address
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
12.11 | 343.89M | 50.51M | -29.63M | 0 | -1.1459 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Initiated | BTIG Research | Buy |
| Aug-18-25 | Initiated | BofA Securities | Buy |
| Aug-18-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Initiated | Piper Sandler | Overweight |
| Aug-18-25 | Initiated | Truist | Buy |
Carlsmed Inc Stock (CARL) Latest News
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? - sharewise.com
Basic earnings per share (basic EPS) of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carlsmed (CARL) Stock: Jumps +3.57%, Approaching $11.89 2026-05-19Free Signal Network - Newser
Carlsmed (CARL) Down -1.66% — How Low Could It Go? 2026-05-14Earnings Breakout - newser.com
Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Income Statement – LSX:A41CM7 - TradingView
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for Aprevo lumbar - MSN
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Number of shareholders of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Carlsmed, Inc. Dividends – LS:A41CM7 - TradingView
Number of employees of Carlsmed, Inc. – LS:A41CM7 - TradingView
Operating expenses (excl. COGS) of Carlsmed, Inc. – LS:A41CM7 - TradingView
Enterprise value to EBITDA ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total debt per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Price to cash flow ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total liabilities of Carlsmed, Inc. – LS:A41CM7 - TradingView
EBIT per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Debt to equity ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LS:A41CM7 - TradingView
Diluted net income available to common stockholders of Carlsmed, Inc. – LS:A41CM7 - TradingView
Cost of goods sold of Carlsmed, Inc. – LS:A41CM7 - TradingView
Operating income of Carlsmed, Inc. – LS:A41CM7 - TradingView
Preferred dividends of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total revenue of Carlsmed, Inc. – LS:A41CM7 - TradingView
Dilution adjustment of Carlsmed, Inc. – LS:A41CM7 - TradingView
Pretax income of Carlsmed, Inc. – LS:A41CM7 - TradingView
Debt to assets ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Free cash flow per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total common shares outstanding of Carlsmed, Inc. – LS:A41CM7 - TradingView
Cash from investing activities of Carlsmed, Inc. – LS:A41CM7 - TradingView
Inventory turnover of Carlsmed, Inc. – LS:A41CM7 - TradingView
Cash from operating activities of Carlsmed, Inc. – LS:A41CM7 - TradingView
Free cash flow of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total liabilities & shareholders' equities of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total operating expenses of Carlsmed, Inc. – LS:A41CM7 - TradingView
Price to sales ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Diluted earnings per share (diluted EPS) of Carlsmed, Inc. – LS:A41CM7 - TradingView
Enterprise value of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed, Inc. Financial Statements – LS:A41CM7 - TradingView
EBITDA of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed, Inc. Cash Flow – LS:A41CM7 - TradingView
Long term debt to total equity ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Return on invested capital % of Carlsmed, Inc. – LS:A41CM7 - TradingView
EBIT of Carlsmed, Inc. – LS:A41CM7 - TradingView
Price to earnings ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed, Inc. Balance Sheet – LS:A41CM7 - TradingView
Carlsmed, Inc. Statistics – LS:A41CM7 - TradingView
Carlsmed Inc Stock (CARL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
4.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):